<SEC-DOCUMENT>0001104659-21-110596-index.html : 20210827
<SEC-HEADER>0001104659-21-110596.hdr.sgml : 20210827
<ACCEPTANCE-DATETIME>20210827170125
ACCESSION NUMBER:		0001104659-21-110596
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210825
FILED AS OF DATE:		20210827
DATE AS OF CHANGE:		20210827

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Coiante Scott M
		CENTRAL INDEX KEY:			0001608536

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39069
		FILM NUMBER:		211219927

	MAIL ADDRESS:	
		STREET 1:		101 POOR FARM ROAD 3RD FLOOR
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aprea Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781983
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		6095104718

	MAIL ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2126037-2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2126037-2_4seq1.html

Document 1 - RAW XML: tm2126037-2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>